Gail V. Johnson - Publications

Affiliations: 
Cell Biology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Cell Biology, Molecular Biology, Neuroscience Biology

70/263 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Isei MO, Girardi PA, Rodwell-Bullock J, Nehrke K, Johnson GV. Site-specific phosphorylation of tau impacts mitochondrial biology and response to stressors. Biorxiv : the Preprint Server For Biology. PMID 36824940 DOI: 10.1101/2023.02.19.529131  0.461
2019 Ji C, Tang M, Zeidler C, Höhfeld J, Johnson GV. BAG3 and SYNPO (synaptopodin) facilitate phospho-MAPT/Tau degradation via autophagy in neuronal processes. Autophagy. PMID 30744518 DOI: 10.1080/15548627.2019.1580096  0.472
2016 Kim S, Choi KJ, Cho SJ, Yun SM, Jeon JP, Koh YH, Song J, Johnson GV, Jo C. Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors. Scientific Reports. 6: 24933. PMID 27112200 DOI: 10.1038/srep24933  0.502
2015 Pallo SP, DiMaio J, Cook A, Nilsson B, Johnson GV. Mechanisms of tau and Aβ-induced excitotoxicity. Brain Research. PMID 26731336 DOI: 10.1016/J.Brainres.2015.12.048  0.418
2015 Chesser AS, Ganeshan V, Yang J, Johnson GV. Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons. Nutritional Neuroscience. PMID 26207957 DOI: 10.1179/1476830515Y.0000000038  0.526
2015 Pallo SP, Johnson GV. Tau facilitates Aβ-induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neurons. Neuroscience Letters. 597: 32-7. PMID 25888814 DOI: 10.1016/j.neulet.2015.04.021  0.462
2015 Zare-Shahabadi A, Masliah E, Johnson GV, Rezaei N. Autophagy in Alzheimer's disease. Reviews in the Neurosciences. PMID 25870960 DOI: 10.1515/Revneuro-2014-0076  0.402
2015 Lei Z, Brizzee C, Johnson GV. BAG3 facilitates the clearance of endogenous tau in primary neurons. Neurobiology of Aging. 36: 241-8. PMID 25212465 DOI: 10.1016/j.neurobiolaging.2014.08.012  0.31
2014 Kim S, Lee D, Song JC, Cho SJ, Yun SM, Koh YH, Song J, Johnson GV, Jo C. NDP52 associates with phosphorylated tau in brains of an Alzheimer disease mouse model. Biochemical and Biophysical Research Communications. 454: 196-201. PMID 25450380 DOI: 10.1016/j.bbrc.2014.10.066  0.5
2014 Quintanilla RA, von Bernhardi R, Godoy JA, Inestrosa NC, Johnson GV. Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons. Neurobiology of Disease. 71: 260-9. PMID 25134729 DOI: 10.1016/j.nbd.2014.08.016  0.453
2014 Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GV. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nature Communications. 5: 3496. PMID 24667209 DOI: 10.1038/Ncomms4496  0.493
2014 Cho C, Kim S, Cho S, Choi K, Yun S, Koh YH, Johnson G, Park SI. Sulforaphane Promotes The Degradation Of Phosphorylated Tau Via The Induction Of Autophagy Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.691  0.503
2014 Chesser A, Lei Z, Johnson GV. P1-005: SELECTIVELY ENHANCING PATHOLOGICAL FORMS OF TAU VIA THE AUTOPHAGY PATHWAY Alzheimer's & Dementia. 10: P306-P306. DOI: 10.1016/j.jalz.2014.05.240  0.318
2013 Chesser AS, Pritchard SM, Johnson GV. Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease. Frontiers in Neurology. 4: 122. PMID 24027553 DOI: 10.3389/fneur.2013.00122  0.508
2012 Jin YN, Chen PC, Watson JA, Walters BJ, Phillips SE, Green K, Schmidt R, Wilson JA, Johnson GV, Roberson ED, Dobrunz LE, Wilson SM. Usp14 deficiency increases tau phosphorylation without altering tau degradation or causing tau-dependent deficits. Plos One. 7: e47884. PMID 23144711 DOI: 10.1371/Journal.Pone.0047884  0.553
2012 Quintanilla RA, Dolan PJ, Jin YN, Johnson GV. Truncated tau and Aβ cooperatively impair mitochondria in primary neurons. Neurobiology of Aging. 33: 619.e25-35. PMID 21450370 DOI: 10.1016/J.Neurobiolaging.2011.02.007  0.695
2011 Dolan PJ, Jin YN, Hwang W, Johnson GV. Decreases in valosin-containing protein result in increased levels of tau phosphorylated at Ser262/356. Febs Letters. 585: 3424-9. PMID 21983102 DOI: 10.1016/J.Febslet.2011.09.032  0.724
2011 Pritchard SM, Dolan PJ, Vitkus A, Johnson GV. The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics. Journal of Cellular and Molecular Medicine. 15: 1621-35. PMID 21348938 DOI: 10.1111/J.1582-4934.2011.01273.X  0.718
2011 Chun W, Waldo GS, Johnson GV. Split GFP complementation assay for quantitative measurement of tau aggregation in situ. Methods in Molecular Biology (Clifton, N.J.). 670: 109-23. PMID 20967587 DOI: 10.1007/978-1-60761-744-0_9  0.385
2010 Dolan PJ, Johnson GV. The role of tau kinases in Alzheimer's disease. Current Opinion in Drug Discovery & Development. 13: 595-603. PMID 20812151  0.723
2010 Dolan PJ, Johnson GV. A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. The Journal of Biological Chemistry. 285: 21978-87. PMID 20466727 DOI: 10.1074/jbc.M110.110940  0.734
2010 Filiano AJ, Tucholski J, Dolan PJ, Colak G, Johnson GV. Transglutaminase 2 protects against ischemic stroke. Neurobiology of Disease. 39: 334-43. PMID 20451610 DOI: 10.1016/J.Nbd.2010.04.018  0.601
2009 Quintanilla RA, Matthews-Roberson TA, Dolan PJ, Johnson GV. Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease. The Journal of Biological Chemistry. 284: 18754-66. PMID 19389700 DOI: 10.1074/Jbc.M808908200  0.68
2008 Matthews-Roberson TA, Quintanilla RA, Ding H, Johnson GV. Immortalized cortical neurons expressing caspase-cleaved tau are sensitized to endoplasmic reticulum stress induced cell death. Brain Research. 1234: 206-12. PMID 18718455 DOI: 10.1016/J.Brainres.2008.07.111  0.362
2008 Ding H, Johnson GV. The last tangle of tau. Journal of Alzheimer's Disease : Jad. 14: 441-7. PMID 18688096 DOI: 10.3233/Jad-2008-14413  0.447
2008 Ding H, Dolan PJ, Johnson GV. Histone deacetylase 6 interacts with the microtubule-associated protein tau. Journal of Neurochemistry. 106: 2119-30. PMID 18636984 DOI: 10.1111/J.1471-4159.2008.05564.X  0.698
2008 Ding H, Johnson GV. New application of beta-galactosidase complementation to monitor tau self-association. Journal of Neurochemistry. 106: 1545-51. PMID 18498442 DOI: 10.1111/J.1471-4159.2008.05496.X  0.375
2007 Chun W, Waldo GS, Johnson GV. Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage. Journal of Neurochemistry. 103: 2529-39. PMID 17908237 DOI: 10.1111/J.1471-4159.2007.04941.X  0.357
2007 Chun W, Johnson GV. Activation of glycogen synthase kinase 3beta promotes the intermolecular association of tau. The use of fluorescence resonance energy transfer microscopy. The Journal of Biological Chemistry. 282: 23410-7. PMID 17565981 DOI: 10.1074/Jbc.M703706200  0.423
2007 Ruan Q, Johnson GV. Transglutaminase 2 in neurodegenerative disorders. Frontiers in Bioscience : a Journal and Virtual Library. 12: 891-904. PMID 17127346 DOI: 10.2741/2111  0.332
2007 Chun W, Johnson GV. The role of tau phosphorylation and cleavage in neuronal cell death. Frontiers in Bioscience : a Journal and Virtual Library. 12: 733-56. PMID 17127334 DOI: 10.2741/2097  0.533
2006 Mi K, Johnson GV. The role of tau phosphorylation in the pathogenesis of Alzheimer's disease. Current Alzheimer Research. 3: 449-63. PMID 17168644 DOI: 10.2174/156720506779025279  0.506
2006 Clodfelder-Miller BJ, Zmijewska AA, Johnson GV, Jope RS. Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes. 55: 3320-5. PMID 17130475 DOI: 10.2337/Db06-0485  0.438
2006 Johnson GV. Tau phosphorylation and proteolysis: insights and perspectives. Journal of Alzheimer's Disease : Jad. 9: 243-50. PMID 16914862  0.415
2006 Ding H, Matthews TA, Johnson GV. Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation. The Journal of Biological Chemistry. 281: 19107-14. PMID 16687396 DOI: 10.1074/Jbc.M511697200  0.451
2006 Mi K, Dolan PJ, Johnson GV. The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity. The Journal of Biological Chemistry. 281: 4787-94. PMID 16365045 DOI: 10.1074/Jbc.M508657200  0.642
2005 Matthews TA, Johnson GV. 14-3-3Zeta does not increase GSK3beta-mediated tau phosphorylation in cell culture models. Neuroscience Letters. 384: 211-6. PMID 15963640 DOI: 10.1016/J.Neulet.2005.04.101  0.45
2005 Stoothoff WH, Johnson GV. Tau phosphorylation: physiological and pathological consequences. Biochimica Et Biophysica Acta. 1739: 280-97. PMID 15615646 DOI: 10.1016/J.Bbadis.2004.06.017  0.526
2005 Stoothoff WH, Cho JH, McDonald RP, Johnson GV. FRAT-2 preferentially increases glycogen synthase kinase 3 beta-mediated phosphorylation of primed sites, which results in enhanced tau phosphorylation. The Journal of Biological Chemistry. 280: 270-6. PMID 15522877 DOI: 10.1074/Jbc.M410061200  0.305
2004 Johnson GV, Stoothoff WH. Tau phosphorylation in neuronal cell function and dysfunction. Journal of Cell Science. 117: 5721-9. PMID 15537830 DOI: 10.1242/Jcs.01558  0.548
2004 Cho JH, Johnson GV. Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. The Journal of Biological Chemistry. 279: 54716-23. PMID 15494420 DOI: 10.1074/jbc.M403364200  0.42
2004 Jope RS, Johnson GV. The glamour and gloom of glycogen synthase kinase-3. Trends in Biochemical Sciences. 29: 95-102. PMID 15102436 DOI: 10.1016/J.Tibs.2003.12.004  0.329
2004 Shelton SB, Krishnamurthy P, Johnson GV. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells. Journal of Neuroscience Research. 76: 110-20. PMID 15048935 DOI: 10.1002/Jnr.20051  0.433
2004 Shelton SB, Johnson GV. Cyclin-dependent kinase-5 in neurodegeneration. Journal of Neurochemistry. 88: 1313-26. PMID 15009631 DOI: 10.1111/J.1471-4159.2003.02328.X  0.325
2004 Cho JH, Johnson GV. Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules. Journal of Neurochemistry. 88: 349-58. PMID 14690523  0.444
2004 Krishnamurthy PK, Johnson GV. Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model. The Journal of Biological Chemistry. 279: 7893-900. PMID 14660557 DOI: 10.1074/Jbc.M311203200  0.464
2004 Johnson GV, Jenkins SM. Tau protein in normal and Alzheimer's disease brain. Journal of Alzheimer's Disease : Jad. 1: 307-28. PMID 12214128 DOI: 10.3233/JAD-1999-14-511  0.484
2003 Cho JH, Johnson GV. Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. The Journal of Biological Chemistry. 278: 187-93. PMID 12409305 DOI: 10.1074/jbc.M206236200  0.411
2002 Johnson GV, Bailey CD. Tau, where are we now? Journal of Alzheimer's Disease : Jad. 4: 375-98. PMID 12446970  0.508
2002 Stoothoff WH, Bailey CD, Mi K, Lin SC, Johnson GV. Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta. Journal of Neurochemistry. 83: 904-13. PMID 12421363 DOI: 10.1046/J.1471-4159.2002.01197.X  0.389
2002 Lesort M, Chun W, Tucholski J, Johnson GV. Does tissue transglutaminase play a role in Huntington's disease? Neurochemistry International. 40: 37-52. PMID 11738471 DOI: 10.1046/J.1471-4159.81.S1.20_8.X  0.303
2001 Mookherjee P, Johnson GV. Tau phosphorylation during apoptosis of human SH-SY5Y neuroblastoma cells. Brain Research. 921: 31-43. PMID 11720709 DOI: 10.1016/S0006-8993(01)03074-8  0.461
2001 Grierson AJ, Johnson GV, Miller CC. Three different human tau isoforms and rat neurofilament light, middle and heavy chain proteins are cellular substrates for transglutaminase. Neuroscience Letters. 298: 9-12. PMID 11154823 DOI: 10.1016/S0304-3940(00)01714-6  0.439
2000 Zhang J, Johnson GV. Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells. Journal of Neurochemistry. 75: 2346-57. PMID 11080186 DOI: 10.1046/j.1471-4159.2000.0752346.x  0.497
1999 Johnson GV, Hartigan JA. Tau protein in normal and Alzheimer's disease brain: an update. Journal of Alzheimer's Disease : Jad. 1: 329-51. PMID 12214129 DOI: 10.3233/Jad-1999-14-512  0.502
1999 Davis PK, Johnson GV. The microtubule binding of Tau and high molecular weight Tau in apoptotic PC12 cells is impaired because of altered phosphorylation. The Journal of Biological Chemistry. 274: 35686-92. PMID 10585448 DOI: 10.1074/jbc.274.50.35686  0.377
1999 Hartigan JA, Johnson GV. Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway. The Journal of Biological Chemistry. 274: 21395-401. PMID 10409701 DOI: 10.1074/Jbc.274.30.21395  0.301
1999 Hensley K, Floyd RA, Zheng NY, Nael R, Robinson KA, Nguyen X, Pye QN, Stewart CA, Geddes J, Markesbery WR, Patel E, Johnson GV, Bing G. p38 kinase is activated in the Alzheimer's disease brain. Journal of Neurochemistry. 72: 2053-8. PMID 10217284 DOI: 10.1046/J.1471-4159.1999.0722053.X  0.407
1998 Xie HQ, Johnson GV. Calcineurin inhibition prevents calpain-mediated proteolysis of tau in differentiated PC12 cells. Journal of Neuroscience Research. 53: 153-64. PMID 9671972 DOI: 10.1002/(SICI)1097-4547(19980715)53:2<153::AID-JNR4>3.0.CO;2-6  0.442
1998 Xie H, Litersky JM, Hartigan JA, Jope RS, Johnson GV. The interrelationship between selective tau phosphorylation and microtubule association. Brain Research. 798: 173-83. PMID 9666118 DOI: 10.1016/S0006-8993(98)00407-7  0.437
1997 Xie H, Johnson GV. Ceramide selectively decreases tau levels in differentiated PC12 cells through modulation of calpain I. Journal of Neurochemistry. 69: 1020-30. PMID 9282924 DOI: 10.1046/j.1471-4159.1997.69031020.x  0.324
1997 Johnson GV, Seubert P, Cox TM, Motter R, Brown JP, Galasko D. The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. Journal of Neurochemistry. 68: 430-3. PMID 8978756 DOI: 10.1046/j.1471-4159.1997.68010430.x  0.462
1997 Arnold CS, Johnson GV, Cole RN, Dong DL, Lee M, Hart GW. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. The Journal of Biological Chemistry. 271: 28741-4. PMID 8910513 DOI: 10.1074/Jbc.271.46.28741  0.371
1996 Litersky JM, Johnson GV, Jakes R, Goedert M, Lee M, Seubert P. Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. The Biochemical Journal. 316: 655-60. PMID 8687413 DOI: 10.1042/Bj3160655  0.384
1996 Fleming LM, Weisgraber KH, Strittmatter WJ, Troncoso JC, Johnson GV. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. Experimental Neurology. 138: 252-60. PMID 8620924 DOI: 10.1006/Exnr.1996.0064  0.391
1995 Guttmann RP, Erickson AC, Johnson GV. Tau self-association: stabilization with a chemical cross-linker and modulation by phosphorylation and oxidation state. Journal of Neurochemistry. 64: 1209-15. PMID 7861153 DOI: 10.1046/j.1471-4159.1995.64031209.x  0.447
1995 Seubert P, Mawal-Dewan M, Barbour R, Jakes R, Goedert M, Johnson GV, Litersky JM, Schenk D, Lieberburg I, Trojanowski JQ. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. The Journal of Biological Chemistry. 270: 18917-22. PMID 7642549 DOI: 10.1074/Jbc.270.32.18917  0.451
1995 Fleming LM, Johnson GV. Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP. The Biochemical Journal. 41-7. PMID 7619080 DOI: 10.1042/bj3090041  0.377
1995 Litersky JM, Johnson GV. Phosphorylation of tau in situ: inhibition of calcium-dependent proteolysis. Journal of Neurochemistry. 65: 903-11. PMID 7616252 DOI: 10.1046/j.1471-4159.1995.65020903.x  0.417
1993 Erickson AC, Johnson GV. Metal (Fe3+) affinity chromatography: differential adsorption of tau phosphoproteins. Journal of Neuroscience Methods. 46: 245-9. PMID 8483317 DOI: 10.1016/0165-0270(93)90073-Z  0.44
Low-probability matches (unlikely to be authored by this person)
2014 Olsen KC, Epa AP, Kulkarni AA, Kottmann RM, McCarthy CE, Johnson GV, Thatcher TH, Phipps RP, Sime PJ. Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules. American Journal of Respiratory Cell and Molecular Biology. 50: 737-47. PMID 24175906 DOI: 10.1165/Rcmb.2013-0092Oc  0.296
2007 Hunter JM, Lesort M, Johnson GV. Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease. Journal of Neuroscience Research. 85: 1774-88. PMID 17455294 DOI: 10.1002/Jnr.21287  0.289
2009 Quintanilla RA, Johnson GV. Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease. Brain Research Bulletin. 80: 242-7. PMID 19622387 DOI: 10.1016/j.brainresbull.2009.07.010  0.273
2012 Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, ... ... Johnson GV, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8: 445-544. PMID 22966490 DOI: 10.4161/Auto.19496  0.272
1997 Davis PK, Dudek SM, Johnson GV. Select alterations in protein kinases and phosphatases during apoptosis of differentiated PC12 cells. Journal of Neurochemistry. 68: 2338-47. PMID 9166726 DOI: 10.1046/j.1471-4159.1997.68062338.x  0.272
2007 Mookherjee P, Quintanilla R, Roh MS, Zmijewska AA, Jope RS, Johnson GV. Mitochondrial-targeted active Akt protects SH-SY5Y neuroblastoma cells from staurosporine-induced apoptotic cell death. Journal of Cellular Biochemistry. 102: 196-210. PMID 17340627 DOI: 10.1002/Jcb.21287  0.269
2003 Tucholski J, Johnson GV. Tissue transglutaminase directly regulates adenylyl cyclase resulting in enhanced cAMP-response element-binding protein (CREB) activation. The Journal of Biological Chemistry. 278: 26838-43. PMID 12743114 DOI: 10.1074/jbc.M303683200  0.263
2000 Krishnamurthy PK, Mays JL, Bijur GN, Johnson GV. Transient oxidative stress in SH-SY5Y human neuroblastoma cells results in caspase dependent and independent cell death and tau proteolysis. Journal of Neuroscience Research. 61: 515-23. PMID 10956421 DOI: 10.1002/1097-4547(20000901)61:5<515::Aid-Jnr6>3.0.Co;2-#  0.261
2000 Lesort M, Tucholski J, Miller ML, Johnson GV. Tissue transglutaminase: a possible role in neurodegenerative diseases. Progress in Neurobiology. 61: 439-63. PMID 10748319 DOI: 10.1016/S0301-0082(99)00052-0  0.253
2003 Johnson GV, Bailey CD. The p38 MAP kinase signaling pathway in Alzheimer's disease. Experimental Neurology. 183: 263-8. PMID 14552867  0.25
2008 Filiano AJ, Bailey CD, Tucholski J, Gundemir S, Johnson GV. Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 2662-75. PMID 18375543 DOI: 10.1096/Fj.07-097709  0.25
2012 Gundemir S, Colak G, Tucholski J, Johnson GV. Transglutaminase 2: a molecular Swiss army knife. Biochimica Et Biophysica Acta. 1823: 406-19. PMID 22015769 DOI: 10.1016/J.Bbamcr.2011.09.012  0.244
1992 Kolasa K, Jope RS, Baird MS, Johnson GV. Alterations of choline acetyltransferase, phosphoinositide hydrolysis, and cytoskeletal proteins in rat brain in response to colchicine administration. Experimental Brain Research. 89: 496-500. PMID 1322821 DOI: 10.1007/Bf00229873  0.242
2005 Van Raamsdonk JM, Pearson J, Bailey CD, Rogers DA, Johnson GV, Hayden MR, Leavitt BR. Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease. Journal of Neurochemistry. 95: 210-20. PMID 16181425 DOI: 10.1111/J.1471-4159.2005.03357.X  0.241
2014 Jo C, Kim S, Cho SJ, Choi KJ, Yun SM, Koh YH, Johnson GV, Park SI. Sulforaphane induces autophagy through ERK activation in neuronal cells. Febs Letters. 588: 3081-8. PMID 24952354 DOI: 10.1016/j.febslet.2014.06.036  0.241
1993 Greenwood JA, Troncoso JC, Costello AC, Johnson GV. Phosphorylation modulates calpain-mediated proteolysis and calmodulin binding of the 200-kDa and 160-kDa neurofilament proteins. Journal of Neurochemistry. 61: 191-9. PMID 8515266 DOI: 10.1111/J.1471-4159.1993.Tb03555.X  0.241
2004 Choo YS, Johnson GV, MacDonald M, Detloff PJ, Lesort M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Human Molecular Genetics. 13: 1407-20. PMID 15163634 DOI: 10.1093/Hmg/Ddh162  0.24
2002 Zhang J, Krishnamurthy PK, Johnson GV. Cdk5 phosphorylates p53 and regulates its activity. Journal of Neurochemistry. 81: 307-13. PMID 12064478 DOI: 10.1046/J.1471-4159.2002.00824.X  0.236
2008 Quintanilla RA, Jin YN, Fuenzalida K, Bronfman M, Johnson GV. Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease. The Journal of Biological Chemistry. 283: 25628-37. PMID 18640979 DOI: 10.1074/jbc.M804291200  0.234
1995 Dudek SM, Johnson GV. Postnatal changes in serine/threonine protein phosphatases and their association with the microtubules. Brain Research. Developmental Brain Research. 90: 54-61. PMID 8719329 DOI: 10.1016/0165-3806(96)83486-9  0.234
2013 Song Y, Kirkpatrick LL, Schilling AB, Helseth DL, Chabot N, Keillor JW, Johnson GV, Brady ST. Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules. Neuron. 78: 109-23. PMID 23583110 DOI: 10.1016/J.Neuron.2013.01.036  0.234
2001 Hartigan JA, Xiong WC, Johnson GV. Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2. Biochemical and Biophysical Research Communications. 284: 485-9. PMID 11394906 DOI: 10.1006/Bbrc.2001.4986  0.234
2013 Gundemir S, Colak G, Feola J, Blouin R, Johnson GV. Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization. Biochimica Et Biophysica Acta. 1833: 1-10. PMID 23085038 DOI: 10.1016/J.Bbamcr.2012.10.011  0.232
2006 Tucholski J, Roth KA, Johnson GV. Tissue transglutaminase overexpression in the brain potentiates calcium-induced hippocampal damage. Journal of Neurochemistry. 97: 582-94. PMID 16539654 DOI: 10.1111/j.1471-4159.2006.03780.x  0.23
2001 Chun W, Lesort M, Tucholski J, Ross CA, Johnson GV. Tissue transglutaminase does not contribute to the formation of mutant huntingtin aggregates. The Journal of Cell Biology. 153: 25-34. PMID 11285271 DOI: 10.1083/Jcb.153.1.25  0.229
2002 Zhang J, Luan CH, Chou KC, Johnson GV. Identification of the N-terminal functional domains of Cdk5 by molecular truncation and computer modeling. Proteins. 48: 447-53. PMID 12112670 DOI: 10.1002/prot.10173  0.226
2007 Ruan Q, Quintanilla RA, Johnson GV. Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin. Journal of Neurochemistry. 102: 25-36. PMID 17403029 DOI: 10.1111/j.1471-4159.2007.04491.x  0.223
2018 Ji C, Tang M, Harrison J, Paciorkowski A, Johnson GV. Nuclear transglutaminase 2 directly regulates expression of cathepsin S in rat cortical neurons. The European Journal of Neuroscience. PMID 30239049 DOI: 10.1111/ejn.14159  0.222
2004 Bailey CD, Johnson GV. Developmental regulation of tissue transglutaminase in the mouse forebrain. Journal of Neurochemistry. 91: 1369-79. PMID 15584913 DOI: 10.1111/j.1471-4159.2004.02825.x  0.222
2000 Lesort M, Johnson GV. Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons. Neuroscience. 99: 305-16. PMID 10938436 DOI: 10.1016/S0306-4522(00)00200-1  0.221
2013 Quintanilla RA, Jin YN, von Bernhardi R, Johnson GV. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease. Molecular Neurodegeneration. 8: 45. PMID 24330821 DOI: 10.1186/1750-1326-8-45  0.22
1998 Lesort M, Attanavanich K, Zhang J, Johnson GV. Distinct nuclear localization and activity of tissue transglutaminase. The Journal of Biological Chemistry. 273: 11991-4. PMID 9575137 DOI: 10.1074/Jbc.273.20.11991  0.219
2010 Jin YN, Johnson GV. The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease. Journal of Bioenergetics and Biomembranes. 42: 199-205. PMID 20556492 DOI: 10.1007/s10863-010-9286-7  0.217
2000 Lesort M, Tucholski J, Zhang J, Johnson GV. Impaired mitochondrial function results in increased tissue transglutaminase activity in situ. Journal of Neurochemistry. 75: 1951-61. PMID 11032884 DOI: 10.1046/J.1471-4159.2000.0751951.X  0.212
1997 Spear N, Estévez AG, Barbeito L, Beckman JS, Johnson GV. Nerve growth factor protects PC12 cells against peroxynitrite-induced apoptosis via a mechanism dependent on phosphatidylinositol 3-kinase. Journal of Neurochemistry. 69: 53-9. PMID 9202293 DOI: 10.1046/J.1471-4159.1997.69010053.X  0.21
2001 Chun W, Lesort M, Tucholski J, Faber PW, MacDonald ME, Ross CA, Johnson GV. Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells. Neurobiology of Disease. 8: 391-404. PMID 11442349 DOI: 10.1006/Nbdi.2001.0390  0.207
2000 Guttmann RP, Johnson GV. Measurement of calpain activity in vitro and in situ using a fluorescent compound and tau as substrates Methods in Molecular Biology (Clifton, N.J.). 144: 143-150. PMID 10818759  0.206
2018 Liu C, Luo R, Wang W, Peng Z, Zhou Z, Milewicz D, Johnson G, Kellems R, Xia Y. Abstract P118: Tissue Transglutaminase Contributes to Pro-Inflammatory Cytokine LIGHT-Induced Ang II Sensitization Hypertension. 72. DOI: 10.1161/Hyp.72.Suppl_1.P118  0.204
2014 Eckert RL, Kaartinen MT, Nurminskaya M, Belkin AM, Colak G, Johnson GV, Mehta K. Transglutaminase regulation of cell function. Physiological Reviews. 94: 383-417. PMID 24692352 DOI: 10.1152/Physrev.00019.2013  0.201
1992 Jope RS, Johnson GV. Neurotoxic effects of dietary aluminium Ciba Foundation Symposium. 169: 254-262; discussion . PMID 1337035  0.2
1998 Zhang J, Guttmann RP, Johnson GV. Tissue transglutaminase is an in situ substrate of calpain: regulation of activity. Journal of Neurochemistry. 71: 240-7. PMID 9648871 DOI: 10.1046/j.1471-4159.1998.71010240.x  0.199
2016 Monteagudo A, Ji C, Akbar A, Keillor JW, Johnson GV. Inhibition or ablation of transglutaminase 2 impairs astrocyte migration. Biochemical and Biophysical Research Communications. PMID 27899316 DOI: 10.1016/J.Bbrc.2016.11.137  0.199
2004 Ruan Q, Lesort M, MacDonald ME, Johnson GV. Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway. Human Molecular Genetics. 13: 669-81. PMID 14962977 DOI: 10.1093/Hmg/Ddh082  0.196
2005 Choo YS, Mao Z, Johnson GV, Lesort M. Increased glutathione levels in cortical and striatal mitochondria of the R6/2 Huntington's disease mouse model. Neuroscience Letters. 386: 63-8. PMID 15993538 DOI: 10.1016/J.Neulet.2005.05.065  0.194
2002 Watcharasit P, Bijur GN, Zmijewski JW, Song L, Zmijewska A, Chen X, Johnson GV, Jope RS. Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage. Proceedings of the National Academy of Sciences of the United States of America. 99: 7951-5. PMID 12048243 DOI: 10.1073/Pnas.122062299  0.194
2003 Lesort M, Lee M, Tucholski J, Johnson GV. Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders. The Journal of Biological Chemistry. 278: 3825-30. PMID 12458211 DOI: 10.1074/Jbc.M205812200  0.192
2009 Beagle B, Mi K, Johnson GV. Phosphorylation of PPP(S/T)P motif of the free LRP6 intracellular domain is not required to activate the Wnt/beta-catenin pathway and attenuate GSK3beta activity. Journal of Cellular Biochemistry. 108: 886-95. PMID 19711366 DOI: 10.1002/Jcb.22318  0.191
2007 Mi K, Johnson GV. Regulated proteolytic processing of LRP6 results in release of its intracellular domain. Journal of Neurochemistry. 101: 517-29. PMID 17326769 DOI: 10.1111/J.1471-4159.2007.04447.X  0.189
2012 Colak G, Johnson GV. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia. Neurobiology of Disease. 45: 1042-50. PMID 22198379 DOI: 10.1016/J.Nbd.2011.12.023  0.188
2009 Gundemir S, Johnson GV. Intracellular localization and conformational state of transglutaminase 2: implications for cell death. Plos One. 4: e6123. PMID 19568436 DOI: 10.1371/journal.pone.0006123  0.183
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Johnson GV, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356  0.183
2009 Kong PJ, Kil MO, Lee H, Kim SS, Johnson GV, Chun W. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line. Neurological Research. 31: 77-83. PMID 18691453 DOI: 10.1179/174313208X331572  0.181
2023 Emerson J, Delgado T, Girardi P, Johnson GV. Deletion of transglutaminase 2 from astrocytes significantly improves their ability to promote neurite outgrowth on an inhibitory matrix. Biorxiv : the Preprint Server For Biology. PMID 36798305 DOI: 10.1101/2023.02.06.527263  0.181
2012 Jin YN, Hwang WY, Jo C, Johnson GV. Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ. Plos One. 7: e30406. PMID 22276192 DOI: 10.1371/journal.pone.0030406  0.177
2011 Colak G, Keillor JW, Johnson GV. Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation. Plos One. 6: e16665. PMID 21304968 DOI: 10.1371/Journal.Pone.0016665  0.176
2005 Milakovic T, Johnson GV. Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. The Journal of Biological Chemistry. 280: 30773-82. PMID 15983033 DOI: 10.1074/jbc.M504749200  0.176
2010 Beagle B, Johnson GV. Differential modulation of TCF/LEF-1 activity by the soluble LRP6-ICD. Plos One. 5: e11821. PMID 20676368 DOI: 10.1371/Journal.Pone.0011821  0.176
2004 Milakovic T, Tucholski J, McCoy E, Johnson GV. Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. The Journal of Biological Chemistry. 279: 8715-22. PMID 14670969 DOI: 10.1074/Jbc.M308479200  0.174
2012 Johnson KB, Petersen-Jones H, Thompson JM, Hitomi K, Itoh M, Bakker EN, Johnson GV, Colak G, Watts SW. Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2. American Journal of Physiology. Heart and Circulatory Physiology. 302: H1355-66. PMID 22307675 DOI: 10.1152/Ajpheart.00918.2011  0.165
1998 Spear N, Estévez AG, Johnson GV, Bredesen DE, Thompson JA, Beckman JS. Enhancement of peroxynitrite-induced apoptosis in PC12 cells by fibroblast growth factor-1 and nerve growth factor requires p21Ras activation and is suppressed by Bcl-2. Archives of Biochemistry and Biophysics. 356: 41-5. PMID 9681989 DOI: 10.1006/Abbi.1998.0741  0.164
2002 Tucholski J, Johnson GV. Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner. Journal of Neurochemistry. 81: 780-91. PMID 12065637 DOI: 10.1046/j.1471-4159.2002.00859.x  0.162
1998 Zhang J, Lesort M, Guttmann RP, Johnson GV. Modulation of the in situ activity of tissue transglutaminase by calcium and GTP. The Journal of Biological Chemistry. 273: 2288-95. PMID 9442073 DOI: 10.1074/Jbc.273.4.2288  0.161
2005 Mi K, Johnson GV. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway. Journal of Cellular Biochemistry. 95: 328-38. PMID 15778991 DOI: 10.1002/Jcb.20400  0.161
1999 Woolf NJ, Zinnerman MD, Johnson GV. Hippocampal microtubule-associated protein-2 alterations with contextual memory. Brain Research. 821: 241-9. PMID 10064810 DOI: 10.1016/S0006-8993(99)01064-1  0.161
2006 Bailey CD, Johnson GV. The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase. Neurobiology of Aging. 27: 871-9. PMID 15896882 DOI: 10.1016/j.neurobiolaging.2005.04.001  0.16
2010 Beagle B, Johnson GV. AES/GRG5: more than just a dominant-negative TLE/GRG family member. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 239: 2795-805. PMID 20925119 DOI: 10.1002/Dvdy.22439  0.16
1998 Guttmann RP, Johnson GV. Oxidative stress inhibits calpain activity in situ. The Journal of Biological Chemistry. 273: 13331-8. PMID 9582380 DOI: 10.1074/jbc.273.21.13331  0.159
2006 Milakovic T, Quintanilla RA, Johnson GV. Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences. The Journal of Biological Chemistry. 281: 34785-95. PMID 16973623 DOI: 10.1074/jbc.M603845200  0.159
2005 Hunter JM, Crouse AB, Lesort M, Johnson GV, Detloff PJ. Verification of somatic CAG repeat expansion by pre-PCR fractionation. Journal of Neuroscience Methods. 144: 11-7. PMID 15848234 DOI: 10.1016/J.Jneumeth.2004.10.006  0.158
2001 De Sarno P, Lesort M, Bijur GN, Johnson GV, Jope RS. Cholinergic- and stress-induced signaling activities in cells overexpressing wild-type and mutant presenilin-1. Brain Research. 903: 226-30. PMID 11382407 DOI: 10.1016/S0006-8993(01)02428-3  0.155
1998 Johnson GV, Guttmann RP. Calpains: intact and active? Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 19: 1011-8. PMID 9394623 DOI: 10.1002/bies.950191111  0.152
2004 Bailey CD, Graham RM, Nanda N, Davies PJ, Johnson GV. Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases. Molecular and Cellular Neurosciences. 25: 493-503. PMID 15033177 DOI: 10.1016/j.mcn.2003.11.016  0.15
1995 Troncoso JC, Costello AC, Kim JH, Johnson GV. Metal-catalyzed oxidation of bovine neurofilaments in vitro. Free Radical Biology & Medicine. 18: 891-9. PMID 7797097 DOI: 10.1016/0891-5849(94)00224-8  0.144
2002 Chun W, Lesort M, Lee M, Johnson GV. Transient osmotic stress facilitates mutant huntingtin aggregation. Neuroreport. 13: 2543-6. PMID 12499864 DOI: 10.1097/00001756-200212200-00032  0.143
1997 Guttmann RP, Elce JS, Bell PD, Isbell JC, Johnson GV. Oxidation inhibits substrate proteolysis by calpain I but not autolysis. The Journal of Biological Chemistry. 272: 2005-12. PMID 8999893 DOI: 10.1074/jbc.272.3.2005  0.137
2005 Bailey CD, Johnson GV. Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanisms. Journal of Neurochemistry. 92: 83-92. PMID 15606898 DOI: 10.1111/j.1471-4159.2004.02839.x  0.136
2001 Tucholski J, Lesort M, Johnson GV. Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience. 102: 481-91. PMID 11166134 DOI: 10.1016/S0306-4522(00)00482-6  0.135
2004 Suh MD, Park CH, Kim SS, Kil MO, Lee GH, Johnson GV, Chun W. Tissue transglutaminase is not involved in the aggregate formation of stably expressed alpha-synuclein in SH-SY5Y human neuroblastoma cells. Archives of Pharmacal Research. 27: 850-6. PMID 15460447 DOI: 10.1007/Bf02980178  0.13
2002 Chun W, Lesort M, Lee M, Johnson GV. Mutant huntingtin aggregates do not sensitize cells to apoptotic stressors. Febs Letters. 515: 61-5. PMID 11943195 DOI: 10.1016/S0014-5793(02)02436-5  0.121
2016 Gundemir S, Monteagudo A, Akbar A, Keillor JW, Johnson GV. The complex role of transglutaminase 2 in glioblastoma proliferation. Neuro-Oncology. PMID 27591334 DOI: 10.1093/Neuonc/Now157  0.113
2013 Jin YN, Yu YV, Gundemir S, Jo C, Cui M, Tieu K, Johnson GV. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin. Plos One. 8: e57932. PMID 23469253 DOI: 10.1371/Journal.Pone.0057932  0.111
1999 Zhang J, Tucholski J, Lesort M, Jope RS, Johnson GV. Novel bimodal effects of the G-protein tissue transglutaminase on adrenoreceptor signalling. The Biochemical Journal. 343: 541-9. PMID 10527931 DOI: 10.1042/0264-6021:3430541  0.106
2011 Colak G, Filiano AJ, Johnson GV. The application of permanent middle cerebral artery ligation in the mouse. Journal of Visualized Experiments : Jove. PMID 21808231 DOI: 10.3791/3039  0.102
2016 Lin CH, Chen J, Zhang Z, Johnson GV, Cooper AJ, Feola J, Bank A, Shein J, Ruotsalainen HJ, Pihlajaniemi TA, Goligorsky MS. Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney. Kidney International. PMID 27165830 DOI: 10.1016/j.kint.2016.01.030  0.101
2010 Buckley JJ, Hoeltzli SD, Johnson GV. Development of a rapid, high-efficiency, scalable refold for neurotrophin-4. Biotechnology and Applied Biochemistry. 56: 27-34. PMID 20408815 DOI: 10.1042/BA20090306  0.097
1991 Johnson GV, Litersky JM, Whitaker JN. Proteolysis of microtubule-associated protein 2 and tubulin by cathepsin D. Journal of Neurochemistry. 57: 1577-83. PMID 1919574 DOI: 10.1111/j.1471-4159.1991.tb06354.x  0.095
2004 Johnson GV, LeShoure R. Immunoblot analysis reveals that isopeptide antibodies do not specifically recognize the epsilon-(gamma-glutamyl)lysine bonds formed by transglutaminase activity. Journal of Neuroscience Methods. 134: 151-8. PMID 15003381 DOI: 10.1016/j.jneumeth.2003.11.006  0.092
1986 Johnson GV, Ulen TS. Designing public policy toward hazardous wastes: The role of administrative regulations and legal liability rules American Journal of Agricultural Economics. 68: 1266-1271. DOI: 10.2307/1241889  0.089
2011 Olsen KC, Sapinoro RE, Kottmann RM, Kulkarni AA, Iismaa SE, Johnson GV, Thatcher TH, Phipps RP, Sime PJ. Transglutaminase 2 and its role in pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine. 184: 699-707. PMID 21700912 DOI: 10.1164/Rccm.201101-0013Oc  0.08
2011 Johnson G, Dale P. Leading the way. Midwives. 14: 40-1. PMID 24893471  0.08
1997 Johnson GV, Schwintzer CR, Tjepkema JD. The acetylene-induced decline in nitrogenase activity in root nodules of Elaeagnus angustifolia Plant and Soil. 191: 157-161. DOI: 10.1023/A:1004253714621  0.076
2016 Gundemir S, Monteagudo A, Akbar A, Keillor JW, Johnson GV. The complex role of transglutaminase 2 in glioblastoma proliferation. Neuro-Oncology. PMID 28170045 DOI: 10.1093/neuonc/now157  0.075
1988 Miltz D, Braden JB, Johnson GV. Standards versus prices revisited: the case of agricultural non- point source pollution Journal of Agricultural Economics. 39: 360-368. DOI: 10.1111/J.1477-9552.1988.Tb00595.X  0.075
2005 Bailey CD, Tucholski J, Johnson GV. Transglutaminases in neurodegenerative disorders. Progress in Experimental Tumor Research. 38: 139-57. PMID 15746534 DOI: 10.1159/000084238  0.07
2002 Parham JA, Deng SP, Raun WR, Johnson GV. Long-term cattle manure application in soil. I. Effect on soil phosphorus levels, microbial biomass C, and dehydrogenase and phosphatase activities Biology and Fertility of Soils. 35: 328-337. DOI: 10.1007/S00374-002-0476-2  0.068
1970 Bohn HL, Johnson GV, Cliff JH. Detoxification of white phosphorus in soil Journal of Agricultural and Food Chemistry. 18: 1172-1173.  0.066
1988 Foster EW, Barton LL, Johnson GV. Differential cellular response of anabaena variabilis to iron Journal of Plant Nutrition. 11: 1193-1203. DOI: 10.1080/01904168809363878  0.06
1998 Goedeken MW, Johnson GV, Raun WR, Phillips SB. Soil test phosphorus crop response projections to variable rate application in winter wheat Communications in Soil Science and Plant Analysis. 29: 1731-1738.  0.058
2002 Rehman HU, Johnson GV, Taylor AD, Doherty SM. Multifocal osteonecrosis -- a case report. Clinical Rheumatology. 21: 322-3. PMID 12189463 DOI: 10.1007/s100670200084  0.058
2002 Bell GE, Martin DL, Stone ML, Solie JB, Johnson GV. Turf area mapping using vehicle-mounted optical sensors Crop Science. 42: 648-651.  0.058
1991 Johnson GV, Youngblood GJ. Responses of nitrogen-fixing and nitrate-supplied alfalfa (Medicago sativa L.) to iron chelates in an alkaline hydroponic medium Plant and Soil. 130: 219-224. DOI: 10.1007/BF00011876  0.056
1999 Raun WR, Johnson GV, Westerman RL. Fertilizer nitrogen recovery in long-term continuous winter wheat Soil Science Society of America Journal. 63: 645-650.  0.056
2008 Johnson G. Public health: part of the midwife's role. Rcm Midwives : the Official Journal of the Royal College of Midwives. 10: 431. PMID 17985735  0.055
2014 Hall J, Johnson G, Linay D, Macdonald S. The RCM's new ePortfolio for members. Midwives. 14: 30-1. PMID 24893419  0.055
2000 Phillips SB, Raun WR, Johnson GV, Thomason WE. Effect of dual applied phosphorus and gypsum on wheat forage and grain yield Journal of Plant Nutrition. 23: 251-261.  0.053
1999 Phillips SB, Raun WR, Johnson GV. Plant and soil responses to source, rate, and timing of applied N for plains bluestem production Journal of Production Agriculture. 12: 254-257.  0.052
1985 Hartzell CR, Johnson GV. In vivo MAC values and in vitro experimentation. Anesthesia and Analgesia. 64: 386-7. PMID 3985386  0.051
1999 Yulianti JS, Lence BJ, Johnson GV, Takyi AK. Non-point source water quality management under input information uncertainty Journal of Environmental Management. 55: 199-217. DOI: 10.1006/jema.1998.0257  0.051
2007 Johnson GV, Barton LL. Inhibition of iron deficiency stress response in cucumber by rare earth elements. Plant Physiology and Biochemistry : Ppb / SociéTé FrançAise De Physiologie VéGéTale. 45: 302-8. PMID 17481909 DOI: 10.1016/j.plaphy.2007.03.012  0.05
1977 Lou HC, Tweed WA, Johnson G, Jones M, Lassen NA. Breakdown of blood/brain barrier in kernicterus. Lancet. 1: 1062-3. PMID 67529 DOI: 10.1016/S0140-6736(77)91306-X  0.049
2006 Barton LL, Johnson GV, Bishop YM. The metabolism of iron by nitrogen-fixing rhizospheric bacteria Iron Nutrition in Plants and Rhizospheric Microorganisms. 199-214. DOI: 10.1007/1-4020-4743-6-9  0.049
1994 Davis PK, Johnson GV. Monoclonal antibody Alz-50 reacts with bovine and human serum albumin. Journal of Neuroscience Research. 39: 589-94. PMID 7534357 DOI: 10.1002/jnr.490390510  0.048
2003 Johnson GV, Raun WR. Nitrogen response index as a guide to fertilizer management Journal of Plant Nutrition. 26: 249-262. DOI: 10.1081/PLN-120017134  0.048
1970 Katnik RJ, Johnson GV. Gas chromatographic analysis of cyclohexane oxidation products Journal of Chromatographic Science. 8: 543-545. DOI: 10.1093/chromsci/8.9.543  0.047
2008 Johnson G. To B or not to B? Interview by Angela Foster Nursing Standard (Royal College of Nursing (Great Britain) : 1987). 22: 21. PMID 18763652  0.045
2000 Lees HL, Raun WR, Johnson GV. Increased plant nitrogen loss with increasing nitrogen applied in winter wheat observed with 15Nitrogen Journal of Plant Nutrition. 23: 219-230.  0.045
1998 Sembiring H, Raun WR, Johnson GV. Nitrogen accumulation efficiency: Relationship between excess fertilizer and soil-plant biological activity in winter wheat Journal of Plant Nutrition. 21: 1235-1252.  0.044
1979 TSUJITA MJ, MURR DP, JOHNSON G. LEAF SENESCENCE OF EASTER LILY AS INFLUENCED BY ROOT/SHOOT GROWTH, PHOSPHORUS NUTRITION AND ANCYMIDOL Canadian Journal of Plant Science. 59: 757-761. DOI: 10.4141/cjps79-117  0.043
1980 Johnson GV, Westerman RL. Improving soil testing credibility Communications in Soil Science and Plant Analysis. 11: 251-255. DOI: 10.1080/00103628009367033  0.042
2012 Johnson G. Leadership. What's that got to do with me? Midwives. 15: 52-53. PMID 24868729  0.041
1997 Kanampiu FK, Raun WR, Johnson GV. Effect of nitrogen rate on plant nitrogen loss in winter wheat varieties Journal of Plant Nutrition. 20: 389-404.  0.041
1995 Yulianti JS, Lence BJ, Johnson GV. Uncertainty analysis in non-point source water quality management decisions . 400-403.  0.041
1987 Johnson GV. Routine Analysis of Oxygenates and Benzene in Retail Motor Fuel: A Survey by the State of Alabama Journal of Chromatographic Science. 25: 65-70. DOI: 10.1093/chromsci/25.2.65  0.04
1999 Raun WR, Johnson GV. Improving nitrogen use efficiency for cereal production Agronomy Journal. 91: 357-363.  0.04
2014 Hunter L, Johnson G, Hall J. Online improvements. Midwives. 17: 52-3. PMID 24960966  0.039
1980 Barton LL, Foster EW, Johnson GV. Viability changes in human neutrophils and monocytes following exposure to toxin extracted from Aphanizomenon flos-aquae. Canadian Journal of Microbiology. 26: 272-4. PMID 6773647 DOI: 10.1139/m80-044  0.039
1986 Barton LL, Orbock Miller S, Johnson GV. The effect of azospirillum brasilense on iron absorption and translocation by sorghum Journal of Plant Nutrition. 9: 557-565. DOI: 10.1080/01904168609363466  0.038
1988 Dennis GL, Fresquez PR, Johnson GV. Iron uptake by native grasses in a sewage sludge amended semiarid grassland Journal of Plant Nutrition. 11: 1417-1427. DOI: 10.1080/01904168809363898  0.038
1988 Barton LL, Johnson GV. Dynamics of iron movement involving colloids, bacteria, and siderophores in an aqueous alkaline environment Journal of Plant Nutrition. 11: 969-979. DOI: 10.1080/01904168809363861  0.038
2013 Johnson G, Flagler S. Web-based unfolding cases: a strategy to enhance and evaluate clinical reasoning skills. The Journal of Nursing Education. 52: 589-92. PMID 24044385 DOI: 10.3928/01484834-20130919-02  0.038
2006 Ford PL, Johnson GV. Effects of dormant- vs. growing-season fire in shortgrass steppe: Biological soil crust and perennial grass responses Journal of Arid Environments. 67: 1-14. DOI: 10.1016/j.jaridenv.2006.01.020  0.037
1984 Carlson JL, Johnson GV, Ulen TS. An economic analysis of Illinois' new hazardous waste law. P.A. 82-572 Nat. Resour. J.. 24: 883-885.  0.037
1997 Gavi F, Raun WR, Basta NT, Johnson GV. Effect of sewage sludge and ammonium nitrate on wheat yield and soil profile inorganic nitrogen accumulation Journal of Plant Nutrition. 20: 203-218.  0.036
1987 Dias JJ, Johnson GV, Hoskinson J, Sulaiman K. Management of severely displaced medial epicondyle fractures Journal of Orthopaedic Trauma. 1: 59-62. PMID 3506587  0.036
1984 Sain SL, Johnson GV. Selection of Iron-Efficient Soybean Cell Lines Using Plant Cell Suspension Culture Journal of Plant Nutrition. 7: 389-398. DOI: 10.1080/01904168409363205  0.034
1989 Braden JB, Johnson GV, Bouzaher A, Miltz D. Optimal Spatial Management of Agricultural Pollution American Journal of Agricultural Economics. 71: 404-413. DOI: 10.2307/1241598  0.033
1998 Raun WR, Johnson GV, Phillips SB, Westerman RL. Effect of long-term N fertilization on soil organic C and total N in continuous wheat under conventional tillage in Oklahoma Soil and Tillage Research. 47: 323-330. DOI: 10.1016/S0167-1987(98)00120-2  0.033
1996 Barton LL, Johnson GV, Schitoskey K, Wertz M. Siderophore-mediated iron metabolism in growth and nitrogen fixation by alfalfa nodulated with Rhizobium meliloti Journal of Plant Nutrition. 19: 1201-1210. DOI: 10.1080/01904169609365191  0.033
1999 Kumar N, Ramakrishnan V, Johnson GV, Southern S. Endoscopically-assisted excision of scapular osteochondroma Acta Orthopaedica Scandinavica. 70: 394-396. PMID 10569273 DOI: 10.3109/17453679908997832  0.032
1989 Dias JJ, Johnson GV, Finlay DBL, Stoyle TF. Pre-operative evaluation for uncemented hip arthroplasty. The role of computerised tomography Journal of Bone and Joint Surgery - Series B. 71: 43-46. PMID 2915003  0.031
1992 Johnson GV, Thompson AG. The Scott wiring technique for direct repair of lumbar spondylolysis Journal of Bone and Joint Surgery - Series B. 74: 426-430. PMID 1587895  0.03
1998 Sembiring H, Johnson GV, Raun WR. Extractable nitrogen using hot potassium chloride as a mineralization potential index Journal of Plant Nutrition. 21: 1253-1271.  0.029
2000 Thomason WE, Raun WR, Johnson GV. Winter wheat fertilizer nitrogen use efficiency in grain and forage production systems Journal of Plant Nutrition. 23: 1505-1516.  0.029
2004 Johnson GV, Rickard AM, Barton LL. Physiological responses of tomato roots grown in organ culture to iron-deficiency stress Soil Science and Plant Nutrition. 50: 1177-1181. DOI: 10.1080/00380768.2004.10408591  0.028
2015 Hoyle C, Johnson G. Building skills in organizational and systems changes: a DNP-FNP clinical curriculum. The Nurse Practitioner. 40: 14-23. PMID 25774811 DOI: 10.1097/01.NPR.0000461948.38539.fc  0.028
2000 Barton LL, Johnson GV, O'Nan AG, Wagener BM. Inhibition of ferric chelate reductase in alfalfa roots by Cobalt, Nickel, Chromium, and Copper Journal of Plant Nutrition. 23: 1833-1845.  0.028
1989 Wu P‐, Braden JB, Johnson GV. Efficient control of cropland sediment: Storm event versus annual average loads Water Resources Research. 25: 161-168. DOI: 10.1029/Wr025I002P00161  0.027
2014 Brintworth K, Johnson G. Supporting the supervisors. Midwives. 16: 42-3. PMID 24868759  0.025
2011 Bishop YM, Barton LL, Johnson GV. Influence of Methylobacterium on iron translocation in plants. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. 24: 575-80. PMID 21240540 DOI: 10.1007/S10534-011-9408-7  0.025
1991 Cornett JD, Johnson GV. Ferric chelate reduction by suspension culture cells and roots of soybean: A kinetic comparison Plant and Soil. 130: 75-80. DOI: 10.1007/BF00011858  0.024
1983 Eleveld B, Johnson GV, Dumsday RG. SOILEC: simulating the economics of soil conservation Journal of Soil &Amp; Water Conservation. 38: 387-389.  0.022
2014 Jones KR, Van Belle LA, Johnson GV, Simmons RW. Beyond the common core and the politics of education reform: The role of school counselors and teachers in facilitating the college and career readiness of urban students Advances in Education in Diverse Communities: Research, Policy and Praxis. 10: 45-70. DOI: 10.1108/S1479-358X20130000010003  0.022
1997 Phillips SB, Raun WR, Johnson GV. Seasonal and long-term changes in nitrate-nitrogen content of well water in Oklahoma Journal of Environmental Quality. 26: 1632-1637.  0.022
1994 Bender MJ, Johnson GV, Simonovic SP. Sustainable management of renewable resources: a comparison of alternative decision approaches International Journal of Sustainable Development &Amp; World Ecology. 1: 77-88. DOI: 10.1080/13504509409469863  0.022
1995 Sembiring H, Raun WR, Johnson GV, Boman RK. Effect of wheat straw inversion on soil water conservation Soil Science. 159: 81-89.  0.021
1987 Wagenknecht JH, Johnson GV. ELECTROCHEMICAL SYNTHESIS OF N,O-DIALKYLARYLHYDROXYLAMINES AND N, O-DIACYLARYLHYDROXYLAMINES Journal of the Electrochemical Society. 134: 2754-2761.  0.021
1982 Johnson GV. Application of High Performance Liquid Chromatography in the Characterization of Iron Stress Response Journal of Plant Nutrition. 5: 499-514. DOI: 10.1080/01904168209362977  0.02
1990 Minter DL, Westerman RL, Johnson GV. Humidification for icap-aes analysis of salt extracts of soils1 Communications in Soil Science and Plant Analysis. 21: 1587-1606. DOI: 10.1080/00103629009368325  0.02
2005 Lewin D, Fearon B, Hemmings V, Johnson G. Women's experiences of vaginal examinations in labour. Midwifery. 21: 267-77. PMID 16024148 DOI: 10.1016/j.midw.2004.10.003  0.019
2014 Johnson G. Healthy families: the key to a healthy future. Midwives. 11: 30. PMID 24902178  0.019
1986 Cress WA, Johnson GV, Barton LL. The role of endomycorrhizal fungi in iron uptake by hilaria jamesii Journal of Plant Nutrition. 9: 547-556. DOI: 10.1080/01904168609363465  0.018
1997 Sy HA, Faminow MD, Johnson GV, Crow G. Estimating the values of cattle characteristics using an ordered probit model American Journal of Agricultural Economics. 79: 463-476.  0.017
2007 Johnson G. Defending your position as expert witness. Rcm Midwives : the Official Journal of the Royal College of Midwives. 10: 38-9. PMID 17294779  0.017
1976 Johnson GV, Tingey S. Matrix organization: blueprint of nursing care organization for the 80s Hospital &Amp; Health Services Administration. 21: 27-39. PMID 1022725  0.017
1994 Allen ER, Johnson GV, Unruh LG. Current approaches to soil testing methods: problems and solutions Soil Testing: Prospects For Improving Nutrient Recommendations. 203-220.  0.016
1992 McElreath DL, Westerman RL, Johnson GV. Comparison of soil extraction parameters for al, mn, ca, and mg determinations Communications in Soil Science and Plant Analysis. 23: 2479-2492. DOI: 10.1080/00103629209368751  0.016
1947 JOHNSON GV. Teaching self-feeding to children with cerebral palsy Public Health Nursing. 39: 310. PMID 20241705  0.014
2000 Tjepkema JD, Schwintzer CR, Burris RH, Johnson GV, Silvester WB. Natural abundance of 15N in actinorhizal plants and nodules Plant and Soil. 219: 285-289.  0.014
2009 Johnson G. Delivering the future Midwives. 12: 48. PMID 24902233  0.014
1984 Hanlon EA, Johnson GV. Bray/kurtz, mehlich III, AB/D and ammonium acetate extractions of p, k and mg in four oklahoma soils Communications in Soil Science and Plant Analysis. 15: 277-294. DOI: 10.1080/00103628409367475  0.013
2012 O'Neil PM, Theim KR, Boeka A, Johnson G, Miller-Kovach K. Changes in weight control behaviors and hedonic hunger during a 12-week commercial weight loss program. Eating Behaviors. 13: 354-60. PMID 23121787 DOI: 10.1016/j.eatbeh.2012.06.002  0.013
2011 Evans B, Potvin C, Johnson G, Henderson N, Yuen I, Smith T, Metham S, Taylor S, Sniekers D. Enhancing patient flow in an acute care hospital: successful strategies at the Juravinski Hospital. Healthcare Quarterly (Toronto, Ont.). 14: 66-74. PMID 21841379  0.013
2009 Johnson G. The new Health in Pregnancy Grant. The Journal of Family Health Care. 18: 198-9. PMID 19113032  0.013
2002 Agarwal S, Tulwa N, Johnson GV. Intercondylar fractures of the femur in the elderly: A treatment option Injury. 33: 735-737. PMID 12213427 DOI: 10.1016/S0020-1383(01)00214-5  0.012
2016 Patow C, Bryan D, Johnson G, Canaan E, Oyewo A, Panda M, Walsh E, Zaidan J. Who's in Our Neighborhood? Healthcare Disparities Experiential Education for Residents. The Ochsner Journal. 16: 41-44. PMID 27046403  0.012
2002 Johnson GV, Lopez A, La Valle Foster N. Reduction and transport of Fe from siderophores Plant and Soil. 241: 27-33. DOI: 10.1023/A:1016007708926  0.012
1990 Johnson GV. International symposium on soil testing and plant analysis Communications in Soil Science and Plant Analysis. 21: 13-14. DOI: 10.1080/00103629009368283  0.012
2007 Chandran P, Kamath RP, Johnson GV. Intraoperative fractures during uncemented Furlong bipolar hemiarthroplasty European Journal of Orthopaedic Surgery and Traumatology. 17: 273-277. DOI: 10.1007/s00590-006-0157-1  0.011
1964 Johnson GV. On Liapunov Stability vs Bounded Input-Bounded Output Ieee Transactions On Automatic Control. 9: 178-180. DOI: 10.1109/TAC.1964.1105658  0.011
2015 Corris PA, Ryan VA, Small T, Lordan J, Fisher AJ, Meachery G, Johnson G, Ward C. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. Thorax. 70: 442-50. PMID 25714615 DOI: 10.1136/Thoraxjnl-2014-205998  0.01
2018 Rawstron SA, Jackman JM, Serebro E, Johnson G, Cabbad M, Bromberg K, Kondamudi V, Sepkowitz D, Landman D. Perirectal Screening for Carbapenem-Resistant Enterobacteriaceae Obtained From 100 Consecutive Healthy Pregnant Women in Labor at a Brooklyn Hospital: Results and Risk Factors. Infection Control and Hospital Epidemiology. 1-2. PMID 29357953 DOI: 10.1017/ice.2017.295  0.01
2015 Jokinen M, Johnson G. Facilitate a home birth. Midwives. 18: 32-3. PMID 25958449  0.01
2014 Macdonald S, Johnson G, Linay D, Hall J. Learning is just a click away. Midwives. 14: 34-5. PMID 24888157  0.01
2006 Johnson G. Confidentiality and standards of care Rcm Midwives : the Official Journal of the Royal College of Midwives. 9: 486-487. PMID 17195502  0.01
2006 Johnson G, Jacob S. Global health and the NHS. Rcm Midwives : the Official Journal of the Royal College of Midwives. 9: 280. PMID 16886792  0.01
2004 Johnson JJM, Hrycaiko DW, Johnson GV, Halas JM. Self-Talk and Female Youth Soccer Performance Sport Psychologist. 18: 44-59.  0.01
1995 Raun WR, Johnson GV. Soil-plant buffering of inorganic nitrogen in continuous winter wheat Agronomy Journal. 87: 827-834.  0.01
1994 Westerman RL, Boman RK, Raun WR, Johnson GV. Ammonium and nitrate nitrogen in soil profiles of long-term winter wheat fertilization experiments Agronomy Journal. 86: 94-99.  0.01
1988 Johnson GV. Bone banks in the 1980s British Journal of Hospital Medicine. 39: 15. PMID 3282582  0.01
1988 Johnson GV. Elastic stockings British Medical Journal (Clinical Research Ed.). 296: 720. PMID 3128391  0.01
1973 Johnson GV, Young RA. Evaluation of eddha as an extraction and analytical reagent for assessing the iron status of soils Soil Science. 115: 11-17.  0.01
1968 Johnson GV, Young RA. Evaluation of interferences in the spectrophotometric determination of iron with ethylenediamine Di(O-hydroxyphenylacetic acid) Analytical Chemistry. 40: 354-357.  0.01
1937 Johnson GV. Occupational therapy for the spastic hand Occupational Therapy and Rehabilitation. 16: 29-32.  0.01
Hide low-probability matches.